Cambridge-based spin-out Mission Therapeutics has launched following completion of a £6 million Series A funding round led by venture capital firm Sofinnova Partners.
Biotechnology company Autifony Therapeutics has closed a £10 million financing, securing a £5 million investment each from Imperial Innovations and SV Life Sciences.
Mid-market private equity firm Barclays Private Equity has exited Femcare Group, selling its holding in the business to Nasdaq-listed Utah Medical Products for £25 million.
Seed-stage investor The Mercia Fund has merged portfolio companies Hybrid Biosystems and Myotec to form PsiOxus Therapeutics in a deal that has attracted £3.6 million in funding.
Privately owned Neoss, a developer of dental implants based in Harrogate, has secured £5.5 million to fund research and development and global sales expansion.
